Intensity Therapeutics, Inc.
INTS
$3.75
$0.010.27%
NASDAQ
Corporate Info
Website
Phone Number
203 221 7381
Address
1 Enterprise Drive
Suite 430
Shelton, CT 06484-4779
Suite 430
Shelton, CT 06484-4779
Country
United States
Year Founded
2012
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
6
Business Description
Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer relapse and metastasis in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.